ArticleCell death discovery2024

Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model.

Virender Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.